GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (NAS:GNTA) » Definitions » Return-on-Tangible-Equity

Genenta Science SPA (Genenta Science SPA) Return-on-Tangible-Equity : -43.36% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Genenta Science SPA Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Genenta Science SPA's annualized net income for the quarter that ended in Dec. 2023 was $-10.66 Mil. Genenta Science SPA's average shareholder tangible equity for the quarter that ended in Dec. 2023 was $24.58 Mil. Therefore, Genenta Science SPA's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 was -43.36%.

The historical rank and industry rank for Genenta Science SPA's Return-on-Tangible-Equity or its related term are showing as below:

GNTA' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -45.74   Med: -24.39   Max: -20.47
Current: -45.74

During the past 5 years, Genenta Science SPA's highest Return-on-Tangible-Equity was -20.47%. The lowest was -45.74%. And the median was -24.39%.

GNTA's Return-on-Tangible-Equity is ranked better than
50.27% of 1305 companies
in the Biotechnology industry
Industry Median: -46.56 vs GNTA: -45.74

Genenta Science SPA Return-on-Tangible-Equity Historical Data

The historical data trend for Genenta Science SPA's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genenta Science SPA Return-on-Tangible-Equity Chart

Genenta Science SPA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
-24.39 -34.55 -20.04 -23.36 -45.96

Genenta Science SPA Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only -11.56 -10.76 -37.42 -48.94 -43.36

Competitive Comparison of Genenta Science SPA's Return-on-Tangible-Equity

For the Biotechnology subindustry, Genenta Science SPA's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genenta Science SPA's Return-on-Tangible-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genenta Science SPA's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Genenta Science SPA's Return-on-Tangible-Equity falls into.



Genenta Science SPA Return-on-Tangible-Equity Calculation

Genenta Science SPA's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-12.699/( (32.985+22.281 )/ 2 )
=-12.699/27.633
=-45.96 %

Genenta Science SPA's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=-10.656/( (26.873+22.281)/ 2 )
=-10.656/24.577
=-43.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Genenta Science SPA  (NAS:GNTA) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Genenta Science SPA Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Genenta Science SPA's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Genenta Science SPA (Genenta Science SPA) Business Description

Traded in Other Exchanges
Address
Via Olgettina No. 58, Milan, ITA, 20132
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's lead product includes Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.

Genenta Science SPA (Genenta Science SPA) Headlines